Angelo A Izzo Selected Research

salvinorin A

4/2016	The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation.
1/2016	Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization.
8/2012	Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection.
9/2011	Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo A Izzo Research Topics

Disease

19	Tuberculosis (Tuberculoses) 12/2021 - 09/2005
18	Infections 12/2021 - 11/2002
18	Inflammation (Inflammations) 01/2021 - 08/2004
12	Neoplasms (Cancer) 01/2022 - 05/2003
11	Colonic Neoplasms (Colon Cancer) 04/2021 - 08/2009
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2004
9	Colitis 01/2021 - 11/2009
7	Carcinogenesis 12/2020 - 09/2009
6	Obesity 11/2019 - 03/2008
5	Pain (Aches) 04/2015 - 06/2005
5	Aberrant Crypt Foci 04/2014 - 01/2008
4	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020 - 01/2003
4	Polyps 01/2017 - 08/2012
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 08/2009
3	Hypertension (High Blood Pressure) 09/2019 - 01/2005
3	Asthma (Bronchial Asthma) 01/2017 - 01/2016
3	Nausea 05/2016 - 01/2003
3	Cystitis 04/2015 - 05/2014
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015 - 01/2003
3	Vomiting 04/2005 - 01/2003
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 09/2003
2	Breast Neoplasms (Breast Cancer) 11/2019 - 09/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 04/2016
2	Bronchial Hyperreactivity 01/2017 - 01/2016
2	Pneumonia (Pneumonitis) 01/2017 - 01/2016
2	Peritonitis 04/2016 - 12/2002
2	Stomach Ulcer (Gastric Ulcer) 01/2011 - 01/2003
2	Epilepsy (Aura) 10/2009 - 09/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2009 - 03/2006
2	Necrosis 09/2009 - 06/2008
2	Hyperglycemia 04/2008 - 03/2008
2	Alzheimer Disease (Alzheimer's Disease) 02/2007 - 04/2004
2	Gastroesophageal Reflux (GERD) 12/2004 - 01/2003
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2003 - 12/2002
1	COVID-19 06/2021
1	Convalescence 06/2021
1	Virus Diseases (Viral Diseases) 06/2021
1	Hemolysis 12/2020

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 12/2021 - 01/2006
12	EndocannabinoidsIBA 01/2017 - 12/2002
8	CannabinoidsIBA 01/2020 - 12/2002
8	CannabidiolIBA 01/2020 - 03/2006
7	AerosolsIBA 12/2021 - 11/2004
7	AzoxymethaneIBA 04/2021 - 09/2009
7	AntioxidantsIBA 12/2020 - 03/2006
6	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2021 - 05/2013
5	AntigensIBA 01/2020 - 01/2006
5	anandamide (arachidonylethanolamide)IBA 01/2017 - 12/2002
5	Pharmaceutical PreparationsIBA 01/2016 - 04/2005
4	palmidrolIBA 04/2021 - 01/2015
4	Peroxidase (Myeloperoxidase)IBA 01/2020 - 05/2013
4	LipidsIBA 01/2018 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2008
4	salvinorin AIBA 04/2016 - 09/2011
4	Messenger RNA (mRNA)IBA 04/2015 - 09/2014
3	DinitrobenzenesIBA 01/2021 - 11/2009
3	Calcium Gluconate (CBG)IBA 01/2021 - 05/2013
3	Tuberculosis VaccinesIBA 01/2020 - 08/2014
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 05/2013
3	EnzymesIBA 01/2020 - 03/2008
3	CytokinesIBA 01/2018 - 06/2008
3	Croton OilIBA 01/2016 - 06/2012
3	dinitrobenzenesulfonic acidIBA 01/2016 - 01/2015
3	CB2 Cannabinoid ReceptorIBA 04/2015 - 05/2013
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 04/2015 - 12/2002
3	Caspase 3 (Caspase-3)IBA 12/2014 - 08/2012
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2012 - 08/2004
3	RimonabantIBA 09/2011 - 12/2002
2	AcidsIBA 01/2022 - 05/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2021 - 01/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2021 - 01/2015
2	Fish OilsIBA 01/2021 - 01/2020
2	Sulfonic AcidsIBA 01/2021 - 11/2009
2	BCG Vaccine FDA Link 10/2020 - 01/2006
2	InterleukinsIBA 01/2020 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2018
2	DiterpenesIBA 04/2016 - 01/2016
2	CarrageenanIBA 04/2016 - 09/2011
2	cannabigerolIBA 12/2014 - 05/2013
2	BromidesIBA 12/2014 - 04/2014
2	oleoylethanolamideIBA 09/2014 - 04/2008
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2013 - 05/2003
2	Formaldehyde (Formol)FDA Link 08/2012 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 08/2012 - 11/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008 - 06/2008
2	Matrix Metalloproteinases (MMPs)IBA 11/2006 - 11/2002
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2006 - 11/2002
2	Amyloid beta-PeptidesIBA 06/2006 - 04/2004
1	N-acylethanolaminesIBA 01/2022
1	amidaseIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 06/2021
1	SalicylatesIBA 06/2021
1	Cyclin B1IBA 04/2021
1	Chemokine CCL8IBA 01/2021
1	2,4-dinitrobenzenesulfonic acidIBA 01/2021
1	oxidized low density lipoproteinIBA 12/2020

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2003
2	Chemoprevention 01/2017 - 03/2014
1	Euthanasia (Mercy Killing) 12/2021
1	Phytotherapy (Herbal Therapy) 06/2021